4//SEC Filing
BAKER BIOTECH CAPITAL II GP LLC 4
Accession 0001181431-04-039504
CIK 0001060736other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 6:19 PM ET
Size
11.7 KB
Accession
0001181431-04-039504
Insider Transaction Report
Form 4
BAKER JULIAN
Director10% Owner
Transactions
- Purchase
Common Stock
2004-08-06$5.50/sh+4,409$24,250→ 62,682 total(indirect: See footnote) - Purchase
Common Stock
2004-08-05$5.54/sh+17,480$96,860→ 58,273 total(indirect: See footnote)
BAKER BIOTECH CAPITAL II GP LLC
Director10% Owner
Transactions
- Purchase
Common Stock
2004-08-06$5.50/sh+4,409$24,250→ 62,682 total(indirect: See footnote) - Purchase
Common Stock
2004-08-05$5.54/sh+17,480$96,860→ 58,273 total(indirect: See footnote)
BAKER FELIX
Director10% Owner
Transactions
- Purchase
Common Stock
2004-08-06$5.50/sh+4,409$24,250→ 62,682 total(indirect: See footnote) - Purchase
Common Stock
2004-08-05$5.54/sh+17,480$96,860→ 58,273 total(indirect: See footnote)
Footnotes (6)
- [F1]In addition to Baker Biotech Capital II (GP), LLC, this Form 4 is being filed jointly by Julian C. Baker and Felix J. Baker, each of whom has the same business address as Baker Biotech Capital II (GP), LLC and may be deemed to have a pecuniary interest in securities owned by it. Because of certain business relationships with other shareholders of the Issuer, the Reporting Persons have filed on Schedule 13D as if they were a member of a group with such shareholders. However, the Reporting Persons disclaim that they and any other person or persons, including those persons with whom the Reporting Persons have filed a Schedule 13D, in fact constitute a "group" for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, or Rule 13d-5 thereunder, or that they are the beneficial owners of any securities owned by any other person. Felix J. Baker is a director of the Issuer.
- [F2]Represents 15,284 shares of common stock purchased by Baker Biotech Fund II, L.P., and 2,196 shares of common stock purchased by Baker Biotech Fund II (Z), L.P.
- [F3]Represents 50,972 shares of common stock owned directly by Baker Biotech Fund II, L.P., and 7,301 shares of common stock owned directly by Baker Biotech Fund II (Z), L.P.
- [F4]Represents shares of common stock owned directly by Baker Biotech Fund II, L.P., and shares of common stock owned directly by Baker Biotech Fund II (Z), L.P. Baker Biotech Fund II, L.P., and Baker Biotech Fund II (Z), L.P., are each limited partnerships of which the sole general partner is Baker Biotech Capital II, L.P., a limited partnership of which the sole general partner is Baker Biotech Capital II (GP), LLC. Felix J. Baker and Julian C. Baker are the controlling members of Baker Biotech Capital II (GP), LLC.
- [F5]Represents 3,855 shares of common stock purchased by Baker Biotech Fund II, L.P., and 554 shares of common stock purchased by Baker Biotech Fund II (Z), L.P.
- [F6]Represents 54,827 shares of common stock owned directly by Baker Biotech Fund II, L.P., and 7,855 shares of common stock owned directly by Baker Biotech Fund II (Z), L.P.
Documents
Issuer
SEATTLE GENETICS INC /WA
CIK 0001060736
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001244386
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 6:19 PM ET
- Size
- 11.7 KB